Click here for slides on this topic


Nephropathy

Kidney disease resulting from chronic poorly controlled diabetes. The main disease occurs in the glomerulus, where there is basement membrane thickening and mesangial overgrowth leading to proteinuria and reduced glomerular filtration, respectively. Some renal tubular disease may be found as well.
The following content matched the glossary term: Nephropathy

AACE 2015 guidelines Microvascular Complications

Top

Recommendations for managing microvascular complications, including retinopathy, nephropathy, and neuropathy from the 2015 AACE diabetes guidelines 

Endocrine Society Guideline on Diabetes and Pregnancy - Glycemic Targets & Glucose Management

Top

Diabetes Management Guidelines Endocrine Society Guideline on Diabetes and Pregnancy   Source Blumer I, Hadar E, Hadden DR, et al. Diabetes and pregnancy an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013 98(11) 4227 4249. Available here.Refer to

Impact of specific glucose-control strategies on microvascular and macrovascular outcomes in 58,000 adults with type 2 diabetes

Top

Neugebauer R, Fireman B, Roy JA, O’Connor PJ. Impact of specific glucose-control strategies on microvascular and macrovascular outcomes in 58,000 adults with type 2 diabetes. Diabetes Care. 2013;36:3510-3516.

ADA 2016 Children & Adolescents

Top

Recommendations for treating and managing diabetes in children from the 2016 ADA guidelines

ADA 2016 Microvascular Complications Foot Care

Top

Recommendations for preventing and managing microvascular complications of diabetes from the 2016 ADA diabetes guidelines

American Diabetes Association (ADA) Nutrition Guidelines for Adults With Diabetes

Top

Diabetes management guidelines for nutrition from the American Diabetes Association (ADA)

Treating the Patient With Type 2 Diabetes and Renal Impairment – References

Top

Patient case: 58-Year-Old African-American Woman with Type 2 Diabetes, Worsening Kidney Function, and Cardiometabolic Comorbidities  

Presented by NDEI Education Council Member, Vivian A. Fonseca, MD

 

Treating the Patient With Type 2 Diabetes and Renal Impairment – Key Take-Home Messages

Top

Patient case: 58-Year-Old African-American Woman with Type 2 Diabetes, Worsening Kidney Function, and Cardiometabolic Comorbidities

Presented by NDEI Education Council Member, Vivian A. Fonseca, MD

 

Treating the Patient With Type 2 Diabetes and Renal Impairment – Follow-Up Pharmacologic Therapy Considerations Proteinuria

Top

Patient case: 58-Year-Old African-American Woman with Type 2 Diabetes, Worsening Kidney Function, and Cardiometabolic Comorbidities  

Presented by NDEI Education Council Member, Vivian A. Fonseca, MD

 

1 2 3 4 5 Next 

Slide Library Results

Search Results for: Nephropathy Slides Found: 31
Relationship Between Flow-Mediated Brachial Artery Dilation and Weight Loss After Lifestyle Modification
Changes in Flow-Mediated Brachial Artery Dilation After 6 Months of Lifestyle Modification
Meta-Analysis: A1C and CVD in Type 2 Diabetes
RENAAL: Design, Hypothesis, and Baseline Demographics
Compelling Indications for Hypertension Drug Classes
IDNT: REnoprotective Effects of Irbesartan in Type 2 Diabetes
RENAAL: Impact of Losartan in Chronic Kidney Disease
RENAAL: Risk Reduction With Losartan--Design
IRMA 2: Renoprotectie Effects of Irbesartan in Type 2 Diabetes
MICRO-HOPE: ACEI Reduces Risk of Nephropathy and CHF in Patients With Type 2 Diabetes
Steno-2: Effect of Multifactorial Intervention on Diabetic Complications
ADVANCE: Study Design
ADVANCE: Primary Endpoints
ADVANCE Trial: Intensive Blood Glucose Control in Patients With Type 2 Diabetes
ADVANCE Trial: Risk for Major Macrovascular and Microvascular Events
VADT: Comparing Intensive With Standard Glucose Therapy, Primary Outcome
VADT: Comparing Intensive With Standard Glucose Therapy, Secondary Outcomes
VADT: Primary Endpoint
VADT: Effect of BMI on Rates of Severe Hypoglycemia
ADVANCE Post-hoc Analysis: Low HDL-C and Microvascular Event Risk
ADVANCE Post-hoc Analysis: HDL-C Predicts Microvascular Risk
nbESH/ESC Hypertension Guidelines: Hypertension Treatment for Patients With Nephropathy
Diabetes Pregnancy Guidelines Renal Nephropathy | NDEI
Diabetes Complications Hypoglycemia US Adults 2012 | NDEI
Statin Use and the Risk of Microvascular Disease | NDEI
Pregnancy Recommendations ADA Type 1 Diabetes Guidelines | NDEI
AACE 2015 Diabetes Guidelines Nephropathy Management Microvascular | NDEI
Blood Pressure Targets Type 2 Diabetes AHA ADA Guidelines | NDEI
ADA Guidelines Treating Microvascular Complications in Children With Type 1 Diabetes | NDEI
Liraglutide Reduces Microvascular Events LEADER CVOT Diabetes PPT | NDEI
Empagliflozin Reduces Kidney Disease in EMPA-REG OUTCOME CVOT | NDEI